Model 7A | Model 7B | |||
---|---|---|---|---|
Coefficient (Standard error) | Coefficient (Standard error) | |||
Constant | 0.793 | (0.124)*** | 0.600 | (0.128)*** |
Procurement type | ||||
APPL (reference group) | ||||
National tender | 0.121 | (0.213) | −0.164 | (0.223) |
Direct purchase | 0.397 | (0.141)** | 0.180 | (0.152) |
Source and category | ||||
Local generic (reference group) | ||||
Imported originator | 0.712 | (0.205)*** | ||
Imported generic | 0.422 | (0.136)** | ||
Route of administration | ||||
Oral preparation (reference group) | ||||
Injectable drugs | −0.370 | (0.160)* | − 0.415 | (0.158)** |
Other preparations | −0.661 | (0.199)*** | −0.680 | (0.210)*** |
Total quantity (‘000,000 DDDs) | −0.009 | (0.003)** | −0.007 | (0.002)** |
Total expenditure (‘000,000 MYR) | 0.036 | (0.017)* | 0.029 | (0.015) |
Year | ||||
2010 (reference group) | ||||
2011 | −0.088 | (0.066) | −0.044 | (0.064) |
2012 | −0.116 | (0.074) | −0.043 | (0.070) |
2013 | −0.195 | (0.083)* | −0.132 | (0.080) |
2014 | −0.200 | (0.083)* | −0.114 | (0.082) |
Adjusted R-squared | 0.096 | 0.159 | ||
Number of observations | 1265 | 1265 |